Choi, Sang Hyun
Jeon, Sun Kyung
Lee, Seung Soo
Lee, Jeong Min http://orcid.org/0000-0003-0561-8777
Hur, Bo Yun
Kang, Hyo-Jin
Kim, Haeryoung
Park, Yangsoon
Article History
Received: 2 December 2020
Revised: 10 March 2021
Accepted: 2 April 2021
First Online: 26 May 2021
Declarations
:
: The scientific guarantor of this publication is Jeong Min Lee.
: The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
: No complex statistical methods were necessary for this paper.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained.
: Some study subjects (99 of 209 patients) have been previously reported [CitationRef removed–CitationRef removed]. The prior articles evaluated biphenotypic PLCs diagnosed only by the 2010 WHO classification, whereas this study reevaluated the pathologic and radiologic findings of the tumors with emphasis on the changes in pathologic diagnoses and LI-RADS classification results based on the 2010 WHO and 2019 WHO classifications.
: 1Jeon SK, Joo I, Lee DH et al (2019) Combined hepatocellular cholangiocarcinoma: LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imaging. Eur Radiol 29:373-3822Choi SH, Lee SS, Park SH et al (2019) LI-RADS Classification and prognosis of primary liver cancers at gadoxetic acid-enhanced MRI. Radiology 290:388-3973Park SH, Lee SS, Yu E et al (2017) Combined hepatocellular-cholangiocarcinoma: gadoxetic acid-enhanced MRI findings correlated with pathologic features and prognosis. J Magn Reson Imaging 46:267-280
: • retrospective• cross-sectional study• multicenter study